Our principal executive offices are located at 100 Columbia, Aliso Viejo, CA 92656, and our telephone number is (949) 521-7830.
RxSight, Inc. was incorporated in California in 1997 as Calhoun Vision, and changed its name to RxSight, Inc. in October of 2016. RxSight was reincorporated in Delaware in July of 2021.
Our ticker is RXST and our shares are traded on the Nasdaq exchange.
We do not currently have a direct stock purchase plan.
Quarterly and annual reports, as well as other SEC filings, can be accessed on our Investor Relations website or directly from the SEC at www.sec.gov.
Our fiscal year end is December 31.
We do not intend to pay cash dividends on our common stock, as we intend to retain all available funds and any future earnings to support operations and finance the growth and development of our business.
Our independent registered public accountants are Ernst & Young.
We use American Equiniti Trust Company, LLC (EQ) as our transfer agent.
Equiniti Trust Company, LLC (“EQ”)
28 Liberty Street, Floor 53
New York, NY 10005
- If your shares are held in street name (by your broker), you must contact the securities firm holding your stock. If you hold stock certificates in your name, questions can be directed to our transfer agent who can be reached through the information below or by visiting https://www.astfinancial.com/login.
- Shareholder Services: help@astfinancial.com or (800) 937-5449
You can view our Board of Directors by visiting the “Board of Directors” section in the “Corporate Governance” tab.
You can view our management team by visiting About Us section of the RxSight corporate website.
We will issue a press release that includes the date and time of our quarterly earnings results and how to access the discussion of the results. When the release is issued, a webcast event link will be posted on the Events & Presentations section of our website for investors to access the live and recorded discussion of the results.
You can contact Investor Relations via email at IR@rxsight.com.